+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Advances in Cholestatic Liver Disease, An Issue of Clinics in Liver Disease. The Clinics: Internal Medicine Volume 30-3

  • Book

  • August 2026
  • Elsevier Health Science
  • ID: 6252590
In this issue of Clinics in Liver Disease, guest editors Drs. Gidgeon Hirschfield and Aliya Gulamhusein bring their considerable expertise to the topic of Advances in Cholestatic Liver Disease. Top experts discuss the pathophysiological basis to chronic cholestasis alongside a review of the patient journey from diagnostic approach, differential causes, symptom burden, complications, and end stage liver disease.
  • Contains 13 relevant, practice-oriented topics including the scientific basis of cholestatic liver disease and its symptom complex; overlap syndromes with PBC and PSC; genetic cholestatic syndromes; general hepatology concerns for the patient with cholestatic liver disease; PSC-associated cholangiocarcinoma; and more
  • Provides in-depth clinical reviews on advances in cholestatic liver disease, offering actionable insights for clinical practice
  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews

Authors

Gidgeon Hirschfield Director of the Autoimmune Liver Disease Program, UHN Francis Family Liver Clinic and Toronto Centre for Liver Disease, Lily and Terry Horner Chair in Autoimmune Liver Disease Research, University Health Network, University of Toronto, Toronto, Ontario, Canada. Aliya Gulamhusein Assistant Professor and Clinician Investigator, Division of Gastroenterology at the University of Toronto, Staff Hepatologist, Toronto Centre for Liver Disease, Francis Family Liver Clinic, Canada.